Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 27, 2015 10:36 PM ET

Healthcare Equipment and Supplies

Company Overview of Immucor, Inc.

Company Overview

Immucor Inc. and its subsidiaries develop, manufacture, and sell reagents and automated systems used primarily by hospitals, clinical labs, and blood banks in tests to detect and identify certain properties of the cell and serum components of human blood before blood transfusions. The company’s reagent product lines include abo blood grouping and Rh blood typing reagents, anti-human globulin serums, reagent red blood cells, rare serums, antibody potentiators, quality control systems, monoclonal antibody-based reagents, technical proficiency systems, and a fetal bleed screen kit, as well as Capture-P, Capture-R, Capture-CMV, Capture-S, and Capture-R Select reagents. These are used in tests to...

3130 Gateway Drive

PO Box 5625

Norcross, GA 30091

United States

Founded in 1982

1,090 Employees

Phone:

770-441-2051

Fax:

770-441-3807

Key Executives for Immucor, Inc.

Chairman of the Board, Chief Executive Officer and President
Age: 52
Chief Financial Officer, Chief Accounting Officer, Vice President and Vice President of International Transfusion Diagnostics
Age: 53
Vice President of Operations
Vice President of International Finance
Age: 58
Compensation as of Fiscal Year 2015.

Immucor, Inc. Key Developments

Immucor, Inc. expected to report Fiscal Year 2015 results on August 27, 2015. This event was calculated by Capital IQ (Created on August 23, 2015).

Immucor, Inc. expected to report Fiscal Year 2015 results on August 27, 2015. This event was calculated by Capital IQ (Created on August 23, 2015).

Immucor, Inc. Announces Executive Changes

Immucor, Inc. announced the appointment of Jeffrey R. Binder as President, Chief Executive Officer and Chairman of the Board of Directors. Binder succeeds CEO William A. Hawkins III, who now assumes the role of Lead Director on the Immucor Board of Directors. Binder has proven experience in helping companies realize growth opportunities. Prior to joining Immucor, Binder was the President and CEO of Biomet.

Immucor, Inc., Q3 2015 Fixed Income Call, May 06, 2015

Immucor, Inc., Q3 2015 Fixed Income Call, May 06, 2015

Similar Private Companies By Industry

Company Name Region
Veritract, Inc. United States
Mentor Texas L.P. United States
Medina Medical Inc. United States
Ion Bond, LLC United States
PerQsurge United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
October 1, 2014
Sentilus, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Immucor, Inc., please visit www.immucor.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.